Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Dermatofibrosarcoma × BO-112 × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Neurofibrosarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1 Carcinoma, Basal Cell 1

Interventions

Radiotherapy 2 Radiation 2 pazopanib 1 envafolimab 1 Nivolumab 1 Ipilimumab 1 Ifosfamide 1 Doxorubicin 1 BO-112 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420975 2026-03-10

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Jonsson Comprehensive Cancer Center

Phase 1 Active not recruiting

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡